Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma delta-1 T cell receptor (γδ-1 TCR) is a cell surface heterodimer predominantly expressed by Vδ1 γδ T cells. This receptor recognizes a diverse, often non-peptidic repertoire of antigens independently of classical major histocompatibility complex (MHC) presentation, distinguishing it from the αβ T cell receptor. Upon ligand binding, the γδ-1 TCR associates with CD3 subunits to initiate strong signaling cascades, leading to rapid immune effector responses such as cytotoxicity, cytokine release, and modulation of tissue homeostasis. The Vδ1 subset, characterized by specific chemokine receptor expression (such as CCR2, CXCR1), is enriched in epithelial tissues (skin, gut) and plays dual protective and pathological roles, including antitumor activity, infection response, tissue repair, and, if dysregulated, contribution to inflammatory disorders and fibrosis. The unique ligand recognition flexibility (polyspecificity) of γδ-1 TCR enables responses to a broad array of molecular challenges, making it a promising—though complex—target in immunotherapy for cancer and inflammatory diseases.
Activation of γδ T cells → immune effector function, including cytotoxicity and cytokine production via antigen recognition through γδ-1 TCR. Immune modulation (recognition of diverse ligands: proteins, metabolites, posttranslational modifications). Enhancement/reduction of tissue-specific inflammatory responses.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma delta-1 T cell receptor (γδ-1 TCR).